Figure 4.
Drug screening and organoid transplantation.Left panel: Organoid-based drug screening is conducted using high-throughput screening, 3D printing, and microfluidic technologies. Right panel: Cells derived from crypts, ESCs, or iPSCs are cultured into organoids and transplanted onto the mesentery or under the kidney capsule.

Drug screening and organoid transplantation.Left panel: Organoid-based drug screening is conducted using high-throughput screening, 3D printing, and microfluidic technologies. Right panel: Cells derived from crypts, ESCs, or iPSCs are cultured into organoids and transplanted onto the mesentery or under the kidney capsule.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close